| Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy P Zamani, AA Momtazi‐Borojeni, ME Nik, RK Oskuee, A Sahebkar Journal of cellular physiology 233 (7), 5189-5199, 2018 | 85 | 2018 |
| A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy H Farzaneh, ME Nik, M Mashreghi, Z Saberi, MR Jaafari, M Teymouri International journal of pharmaceutics 551 (1-2), 300-308, 2018 | 82 | 2018 |
| Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches A Gowhari Shabgah, A Amir, ZR Gardanova, A Olegovna Zekiy, ... Cancer medicine 10 (15), 5191-5202, 2021 | 55 | 2021 |
| Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma ME Nik, B Malaekeh-Nikouei, M Amin, M Hatamipour, M Teymouri, ... Scientific reports 9 (1), 9527, 2019 | 52 | 2019 |
| Effects of immunization against PCSK9 in an experimental model of breast cancer AA Momtazi-Borojeni, ME Nik, MR Jaafari, M Banach, A Sahebkar Archives of Medical Science 15 (3), 570-579, 2019 | 51 | 2019 |
| Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer AA Momtazi-Borojeni, ME Nik, MR Jaafari, M Banach, A Sahebkar Archives of Medical Science 15 (3), 559-569, 2019 | 36 | 2019 |
| Topical application of curcumin regulates the angiogenesis in diabetic‐impaired cutaneous wound S Dehghani, R Dalirfardouei, MH Jafari Najaf Abadi, M Ebrahimi Nik, ... Cell biochemistry and function 38 (5), 558-566, 2020 | 31 | 2020 |
| Targeted‐nanoliposomal combretastatin A4 (CA‐4) as an efficient antivascular candidate in the metastatic cancer treatment ME Nik, AA Momtazi‐Borojeni, P Zamani, JG Navashenaq, M Iranshahi, ... Journal of Cellular Physiology 234 (9), 14721-14733, 2019 | 25 | 2019 |
| Effects of immunisation against PCSK9 in mice bearing melanoma AA Momtazi-Borojeni, ME Nik, MR Jaafari, M Banach, A Sahebkar Archives of Medical Science 16 (1), 189-199, 2020 | 21 | 2020 |
| The effect of RGD-targeted and non-targeted liposomal Galbanic acid on the therapeutic efficacy of pegylated liposomal doxorubicin: From liposomal preparation to in-vivo studies ME Nik, MR Jaafari, M Mashreghi, S Nikoofal-Sahlabadi, M Amin, ... International journal of pharmaceutics 604, 120710, 2021 | 12 | 2021 |
| Interactive anticancer effect of nanomicellar curcumin and galbanic acid combination therapy with some common chemotherapeutics in colon carcinoma cells A Jafari, M Teymouri, ME Nik, A Abbasi, M Iranshahi, MY Hanafi-Bojd, ... Avicenna journal of phytomedicine 9 (3), 237, 2019 | 9 | 2019 |
| A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation A Gowhari Shabgah, F Jadidi‐Niaragh, F Ebrahimzadeh, H Mohammadi, ... Cell biology international 46 (10), 1557-1570, 2022 | 6 | 2022 |
| Designing new nanoliposomal formulations and evaluating their effects on myeloid‐derived suppressor cells and regulatory T cells in a colon cancer model aiming to develop an … RA Taheri, A Bahramifar, MR Jaafari, M Fasihi‐Ramandi, RZ Emameh, ... Biotechnology and Applied Biochemistry 69 (5), 2151-2160, 2022 | 4 | 2022 |
| Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma ME Nik, B Malaekeh-Nikouei, M Amin, M Hatamipour, M Teymouri, ... Scientific reports 10 (1), 3965, 2020 | 3 | 2020 |
| P673 moderate anti-tumor effect of the nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing colorectal cancer AA Momtazi-Borojeni, ME Nik, MR Jaafari, M Banach, A Sahebkar European Heart Journal 40 (Supplement_1), ehz747. 0279, 2019 | 2 | 2019 |
| 4120 Anti-tumor activity of a nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing 4T1 breast cancer AA Momtazi-Borojeni, ME Nik, MR Jaafari, M Banach, A Sahebkar European Heart Journal 40 (Supplement_1), ehz745. 0123, 2019 | 2 | 2019 |
| Anti-tumor activity of a nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing 4T1 breast cancer AA Momtazi-Borojeni, ME Nik, MR Jaafari, M Banach, A Sahebkar EUROPEAN HEART JOURNAL 40, 2479-2479, 2019 | 1 | 2019 |
| The effect of RGD-targeted and non-targeted liposomal Galbanic acid on the therapeutic efficacy of pegylated liposomal doxorubicin M Ebrahimi Nik, M Reza Jaafari, M Mashreghi, S Nikoofal-Sahlabadi, ... International Journal of Pharmaceutics 604, 2021 | | 2021 |
| Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma (vol 9, 9527, 2019) ME Nik, B Malaekeh-Nikouei, M Amin, M Hatamipour, M Teymouri, ... SCIENTIFIC REPORTS 10 (1), 2020 | | 2020 |
| Moderate anti-tumor effect of the nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing colorectal cancer AA Momtazi-Borojeni, ME Nik, MR Jaafari, M Banach, A Sahebkar EUROPEAN HEART JOURNAL 40, 281-281, 2019 | | 2019 |
